Mixtard human 70/30 and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Mixtard human 70/30 (insulin recombinant purified human; insulin susp isophane semisynthetic purified human), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Lasix, and have Diabetes.

The phase IV clinical study analyzes which people have Weakness when taking Mixtard human 70/30. It is created by eHealthMe based on reports of 1,117 people who have side effects when taking Mixtard human 70/30 from the FDA, and is updated regularly.

What is Mixtard human 70/30?

Mixtard human 70/30 has active ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human. It is often used in type 1 diabetes. eHealthMe is studying from 1,131 Mixtard human 70/30 users. Check the latest studies of Mixtard human 70/30.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,618 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

1,117 people reported to have side effects when taking Mixtard human 70/30.
Among them, 41 people (3.67%) have Weakness.

Could Mixtard human 70/30 cause Weakness?

Among these 41 people:

How long have people been on Mixtard human 70/30 when they have Weakness? *

What is the gender of people who have Weakness when taking Mixtard human 70/30? *

female: 60.98 %
male: 39.02 %

What is the age of people who have Weakness when taking Mixtard human 70/30? *

What are other drugs people take besides Mixtard human 70/30? *

Cordarone: 7 people, 17.07%
Ramipril: 7 people, 17.07%
Lasix: 7 people, 17.07%
Folic Acid: 6 people, 14.63%
Simvastatin: 6 people, 14.63%
Sertraline Hydrochloride: 5 people, 12.20%
Clonazepam: 5 people, 12.20%
Plavix: 5 people, 12.20%
Diltiazem Hydrochloride: 5 people, 12.20%
Lipitor: 5 people, 12.20%

What are other side effects people have besides Weakness? *

Dyspnea (difficult or laboured breathing): 9 people, 21.95%
Blood Creatine Phosphokinase Increased: 8 people, 19.51%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 17.07%
Paraparesis (partial paralysis of the lower limbs): 6 people, 14.63%
Nausea (feeling of having an urge to vomit): 6 people, 14.63%
Hypotonia (low muscle tone): 6 people, 14.63%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 6 people, 14.63%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 14.63%
Dizziness: 5 people, 12.20%
Memory Loss: 5 people, 12.20%

What are the existing conditions these people have? *

Diabetes: 14 people, 34.15%
High Blood Pressure: 7 people, 17.07%
Arthritis Bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection): 5 people, 12.20%
Amputation: 4 people, 9.76%
Pain: 4 people, 9.76%
Neuralgia (pain in one or more nerves): 3 people, 7.32%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 4.88%
Chronic Renal Failure (kidney failure): 2 people, 4.88%
Type 2 Diabetes: 2 people, 4.88%
Neuroendocrine Tumor: 1 person, 2.44%

* Approximation only. Some reports may have incomplete information.

Do you take Mixtard human 70/30 and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mixtard human 70/30:

Mixtard human 70/30 (1,131 reports)

Weakness treatments and more:

Weakness (586,877 reports)

How severe was Weakness and when was it recovered:

Weakness in Mixtard human 70/30

Expand to all the drugs that have ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human:

Weakness and drugs with ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mixtard human 70/30:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,638 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,618 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant purified human; insulin susp isophane semisynthetic purified human (the active ingredients of Mixtard human 70/30) and Mixtard human 70/30 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.